SCHEMBL24762829

SCHEMBL24762829

CC[C@@H](C)CNC(=O)[C@@H](C)CC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
TSHR P16473 2/20 0.38
USP2 O75604 1/20 0.38
MME P08473 1/20 0.37
ACE P12821 1/20 0.37
CPA1 P15085 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
FAAH O00519 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
PDE10A Q9Y233 1/20 0.35
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24762880 1.00 GAA (0.38) GAATSHRUSP2MMEACE
SCHEMBL24762807 1.00 GAA (0.38) GAATSHRUSP2MMEACE
SCHEMBL24762827 1.00 GAA (0.38) GAATSHRUSP2MMEACE
SCHEMBL24762831 1.00 GAA (0.38) GAATSHRUSP2MMEACE
SCHEMBL24762809 1.00 GAA (0.38) GAATSHRUSP2MMEACE
SCHEMBL24762817 1.00 GAA (0.38) GAATSHRUSP2MMEACE
SCHEMBL24762806 1.00 GAA (0.38) GAATSHRUSP2MMEACE
SCHEMBL24763254 0.87 ACE2 (0.36) GAAACE2FAAHCNR1CNR2
SCHEMBL24762810 0.87 ACE2 (0.36) GAAACE2FAAHCNR1CNR2
SCHEMBL24763136 0.87 ACE2 (0.36) GAAACE2FAAHCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230202968-A1 PROCESS FOR PREPARING 2-METHYL-N-(2' -METHYLBUTYL)BUTANAMIDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-29 US disclosed
US-20230202968-A1 PROCESS FOR PREPARING 2-METHYL-N-(2' -METHYLBUTYL)BUTANAMIDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-29 US disclosed
US-20220411363-A1 PROCESS FOR PREPARING 2-METHYL-N-(2' -METHYLBUTYL)BUTANAMIDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-12-29 US disclosed
EP-4101840-A1 PROCESS FOR PREPARING 2-METHYL-N- (2' -METHYLBUTYL) BUTANAMIDE Shin-Etsu Chemical Co., Ltd. (JP) 2022-12-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411363-A1 PROCESS FOR PREPARING 2-METHYL-N-(2' -METHYLBUTYL)BUTANAMIDE ALKBH5, ALKBH2, ADRB2 GAA 1919/4885TSHR 2613/4885USP2 887/4885
US-20230202968-A1 PROCESS FOR PREPARING 2-METHYL-N-(2' -METHYLBUTYL)BUTANAMIDE ALKBH5, ALKBH2, ADRB2 GAA 1919/4885TSHR 2613/4885USP2 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.